Literature DB >> 15774439

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.

M S A Deloire1, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, K G Petry, V Dousset, C Fabrigoule, B Brochet.   

Abstract

OBJECTIVES: To establish the frequency of cognitive impairment in a population based sample of patients with recently diagnosed relapsing-remitting multiple sclerosis (RRMS), and to determine the relation between cognitive abnormalities and the extent of macroscopic and microscopic tissue damage revealed by magnetic resonance imaging (MRI) and magnetisation transfer (MT) imaging.
METHODS: 58 patients with RRMS consecutively diagnosed in the previous six months in Aquitaine and 70 healthy controls underwent a battery of neuropsychological tests. Lesion load and atrophy indices (brain parenchymal fraction and ventricular fraction) were measured on brain MRI. MT ratio (MTR) histograms were obtained from lesions, normal appearing white matter (NAWM), and normal appearing grey matter (NAGM). Gadolinium enhanced lesions were counted.
RESULTS: 44 RRMS patients could be individually matched with healthy controls for age, sex, and education. Patients performed worse in tests of verbal and spatial memory, attention, information processing speed, inhibition, and conceptualisation. Measures of attention and information processing speed were correlated with lesion load, mean NAWM MTR, and the peak location of the NAGM MTR histogram in the patients. Multivariate regression analysis showed that lesion load and mean NAWM MTR were among the MR indices that were most significantly associated with impairment of attention and information processing speed in these early RRMS cases.
CONCLUSIONS: Cognitive impairment appears to be common in the early stages of RRMS, mainly affecting attention, information processing speed, memory, inhibition, and conceptualisation. The severity of these deficits reflects the extent of the lesions and the severity of tissue disorganisation outside lesions.

Entities:  

Mesh:

Year:  2005        PMID: 15774439      PMCID: PMC1739602          DOI: 10.1136/jnnp.2004.045872

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  60 in total

1.  Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis.

Authors:  W W Beatty; D E Goodkin; N Monson; P A Beatty; D Hertsgaard
Journal:  Arch Neurol       Date:  1988-06

2.  Cognitive impairment in patients with multiple sclerosis and mild physical disability.

Authors:  W van den Burg; A H van Zomeren; J M Minderhoud; A J Prange; N S Meijer
Journal:  Arch Neurol       Date:  1987-05

3.  Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales.

Authors:  R P Snaith; F M Harrop; D A Newby; C Teale
Journal:  Br J Psychiatry       Date:  1986-05       Impact factor: 9.319

4.  Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment.

Authors:  S M Rao; S Glatt; T A Hammeke; M P McQuillen; B O Khatri; A M Rhodes; S Pollard
Journal:  Arch Neurol       Date:  1985-07

5.  Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis.

Authors:  R K Heaton; L M Nelson; D S Thompson; J S Burks; G M Franklin
Journal:  J Consult Clin Psychol       Date:  1985-02

6.  Deficient learning and memory in early and middle phases of multiple sclerosis.

Authors:  I Grant; W I McDonald; M R Trimble; E Smith; R Reed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

7.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

8.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Cognitive function in recent-onset demyelinating diseases.

Authors:  O Lyon-Caen; R Jouvent; S Hauser; M P Chaunu; N Benoit; D Widlöcher; F Lhermitte
Journal:  Arch Neurol       Date:  1986-11
View more
  45 in total

Review 1.  Cognitive impairment in early stages of multiple sclerosis.

Authors:  Maria Pia Amato; E Portaccio; B Goretti; V Zipoli; B Hakiki; M Giannini; L Pastò; L Razzolini
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

2.  The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study.

Authors:  Flavia Mattioli; C Stampatori; R Capra
Journal:  Neurol Sci       Date:  2010-09-25       Impact factor: 3.307

3.  Differential cerebellar and cortical involvement according to various attentional load: role of educational level.

Authors:  Melissa C Bonnet; Bixente Dilharreguy; Michele Allard; Mathilde S A Deloire; Klaus G Petry; Bruno Brochet
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

4.  Improvement of neuropsychological function in cognitively impaired multiple sclerosis patients treated with natalizumab: a preliminary study.

Authors:  Keith R Edwards; William A Goodman; Carl Y Ma
Journal:  Int J MS Care       Date:  2012

Review 5.  Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies.

Authors:  Klaus G Petry; Bruno Brochet; Vincent Dousset; Jean Rodolphe Vignes; Claudine Boiziau
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

6.  MRI predictors of cognitive outcome in early multiple sclerosis.

Authors:  M S A Deloire; A Ruet; D Hamel; M Bonnet; V Dousset; B Brochet
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

7.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

8.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

Review 9.  Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.

Authors:  Blandine Grassiot; Béatrice Desgranges; Francis Eustache; Gilles Defer
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

10.  Magnetization transfer imaging in 'premanifest' Huntington's disease.

Authors:  Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.